How do I set a price alert for PLUR?

To set a PLUR price alert on Stock Alarm Pro, navigate to the PLUR quote page, select "Set Alert," choose your trigger type (price target, % move, RSI level, MACD, or volume breakout), and set your delivery channel. Stock Alarm Pro supports instant push notifications, SMS, and automated phone call alerts.

Can I get phone call alerts for PLUR?

Yes. Stock Alarm Pro provides real-time automated phone call alerts for PLUR. Phone call alerts ensure you are immediately awakened or interrupted during critical volatility events, overnight earnings moves, or strict stop-loss levels when silent push notifications might be overlooked.

What types of alerts can I set for PLUR?

Stock Alarm Pro supports over 125 trigger types for PLUR: price target alerts (above/below target), intraday percentage moves, RSI overbought/oversold levels, 50-day and 200-day moving average crossovers (golden cross / death cross), relative volume (RVOL) spikes, confirmed earnings date releases, and SEC Form-4 insider transaction filings.

How quickly will I be notified about PLUR price changes?

PLUR alerts are evaluated continuously in real-time against live market telemetry. Notifications are dispatched within sub-second latency via push notifications, SMS, or phone calls as soon as your trigger condition is met across regular, pre-market, and after-hours trading sessions.

Is Stock Alarm Pro free to use for PLUR alerts?

Yes, Stock Alarm Pro offers a free tier that includes 3 active price alerts for PLUR and other stocks. Full Pro membership is $20/month or $168/year with a 7-day free trial, unlocking unlimited alerts, phone call delivery, SMS, all 125+ technical indicators, institutional screeners, and real-time market telemetry across web, iOS, and Android.

PLUR Price Alerts | Stock Alarm Pro

Pluri Inc.(PLUR)

NASDAQClosing price · checked 4:24 PM ESTAbout this dataData status

$1.20▼-0.04 (-3.23%)Earnings in 3d

Extended:$1.20+0.00 (+0.00%)

WatchlistChart Studio

S&P 500, Nasdaq, Russell 2000 below the 50-day average (VIX 21.1)

Market overview →Overview →

PLUR Fundamentals

Annual and trailing 12-month values

All metrics →All fundamentals →

PLUR News

All news →

About

pluristem therapeutics inc. (nasdaqcm: psti, tase: psti/pltr) is a clinical-stage biotherapy company using placental cells and a unique, proprietary, three-dimensional (3d) technology platform to develop cell therapies for conditions such as inflammation, ischemia, hematological disorders, or exposure to radiation. pluristem’s placental expanded (plx) cells are placenta-derived, mesenchymal-like adherent stromal cells that are designed to be administered to patients without the need for tissue or genetic matching. these cells release soluble biomolecules, such as cytokines, chemokines and growth factors, which act in a paracrine or endocrine manner to facilitate healing of damaged tissues by stimulating the body’s own regenerative mechanisms. the company’s proprietary, 3d expansion technology can be used to grow plx cells in mass quantities with batch-to-batch consistency at pluristem’s fda, ema and pmda-approved, state-of-the art manufacturing facility. pluristem’s first product candi

Sector

Professional, Scientific, and Technical Services

Industry

Research and Development in Biotechnology (except Nanobiotechnology)

CEO

Yaky Yanay

Country

Israel

Website

pluristem.com ↗